Monday, 16 February 2015

15 Super-Potent Pot Strains with Awesome Names


15 Super-Potent Pot Strains with Awesome Names

While hosting the "Daily Show," John Oliver, when speaking about medical marijuana, commented: "If you want this drug with serious medical benefits to be taken seriously, how about adulting up the names a little bit. That way a sick old man doesn't have to ask for a quarter ounce of Rainbow Diesel Funkadelic Cheddar Harmony."
Joking aside, the joyful and descriptive names of pot has a long and esteemed history. Here are our favorites:
1. Green Crack
A cerebral sativa-dominant strain, Green Crack rankled folks in the marijuana community with its naming nod to the cocaine derivative. Green Crack is NOT addictive, and it definitely won’t kill you. You may smoke it and then laugh until you feel like you’re going to die, though.
2. Girl Scout Cookies
The Girl Scouts of America may not like being associated with a cannabis plant named after their oh-so-delicious cookies, but this pot is fruity, spicy and goes down great with a Thin Mint. Mmmmmmm.
3. Jorge’s Diamonds #1
Beautiful glistening colas inspired Dutch breeders to name this strain after their friend and one of our favorite cultivation gurus, Jorge Cervantes. Jorge’s Diamonds #1 shines star bright, packs a crystalline punch… and what stoney girl doesn’t want to sparkle?
4. Blue Cheese
A funky, skunky hybrid of Blueberry and UK Cheese, this pot is popular with canna-sseurs. Perfect with a glass of tawny port after dinner, or perhaps infused in some dippin’ sauce for wings… Uh, we’ll be back after a snack break.
5. Purple Urkel
Steve Urkel, the geeky neighbor on "Family Matters," was known for several catchphrases, including his “Did I do that?” Since Purple Urkel is said to be good for treating insomnia, that sounds like an excellent thing.
6. Chocolope 
A minty, cocoa-y cross of OG Chocolate Thai and Cannalope Haze, Chocolope is as scrumptious as its name. We’d like to smoke a bowl of it with a glass of cold milk on the side, please.
7. Strawberry Cough 
This sativa-dominant winner at the 2013 Seattle U.S. Cannabis Cup has been around for a while, and we’re not surprised. Its strawberry ambrosia and thick, delicious smoke make for a perfect buzz that will get you going… and going… and going.
8. Golden Goat 
A sweet ‘n sour hybrid, Golden Goat was supposedly named for the smell of recycled soda cans rotting in the summer heat. Sticky, stinky and just what we want when we’re working on the farm. Or anywhere, really.  
9. Skywalker OG 
Skywalker’s OG father is… Skywalker! (That’s not a spoiler, right? We’ve all seen the movie.) This indica-heavy strain takes stoners to a galaxy far, far away with its jet-fuel aromas. Now -- where has that pesky sister of his gotten to?
10. Afgooey 
A clone-only strain, Afgooey will turn tokers into a pile of goo-tastic goodness. Its sugary lusciousness can transform a stressful afternoon into a sweet and lowdown sojourn.
11. Trainwreck 
Like a high-speed freight train that hits you when you were looking the other way, Trainwreck can be a major blast of potency… but in this case, “All aboaaard!” Try riding this train to the end of the line for an unexpected adventure.
12. Lucky Charms
Maybe that leprechaun has the right idea. A mellow strain from Colorado, Lucky Charms could help you find the end of whatever rainbow you’re chasing. Hey, you never know -- it might be a double rainbow all the way!
13. Martian Mean Green
Get off the planet for a while and visit some outer space destinations with this sativa-dominant, uplifting pot. You may end up socializing with some pretty cool extraterrestrials… or, you know, just hanging out with human friends.
14. Schnazzleberry
Perhaps with a tip of the hat to Willy Wonka’s snozzberries, Schnazzleberry is evidently great for vaping, making hash, and for getting schnazzy. Put on your wingtip shoes and cocktail attire, and puff, puff, pass.
15. Alaskan Thunderfuck
Hailing from the Manatuska Valley in the 49th state, the Alaskan Thunderfuck will thunderclap your senses with its fruity badassery. This weed from the Great White North can trigger a smoky storm that clears the skies, and your eyes.

25 Greatest Strains of All Time


25 Greatest Strains of All Time



What better way to celebrate HIGH TIMES’ 40th anniversary than to pay homage to the best of the cannabis plant, which provided our founder, Thomas King Forçade, and so many others with the inspiration to cultivate a movement and put forth a publication dedicated to one goal for so many years.
 
You’re probably wondering just how, exactly, we came up with The List? We do admit it’s not a bad gig to have, deciding which strains are the best of all time -- but still, the task did come with its challenges. Sorting through the varied histories of these strains wasn’t exactly easy as the lineage, parentage and even the birthplace of some of these strains are murky at best.
 
So we had to rely on a few main factors, the first being each strain’s influence and overall contribution to the cannabis gene pool -- hence many of the old-school varietals on the list. Next, we had to consider the awards (specifically, Cannabis Cups) that each strain has won. And after that came popularity and market share, qualitative factors that helped shape The List greatly. Lastly, we made use of our movement’s greatest asset: Science. We looked at a host of quantitative characteristics, such as potency (both THC and CBD; see #8 for proof) as well as terpenoid profiles, which produce the flavorful aromas and tastes that we all love so much.
 
Hopefully, we did right by all of HIGH TIMES’ readers. But we’re also pretty confident that if you were starting out on a new planet and had to take a handful of cannabis seeds along, you’d be choosing from among these 25! So here’s to our Lady of Cause, and all of her beautiful children. Enjoy.
 
25. Acapulco Gold, a.k.a. Mexican Sativa 
Kicking off our list of the all-time greatest strains is a true native landrace of North America. Often referred to as Acapulco Gold, but more commonly known these days as Mexican sativa, it is often used in breeding projects which have led to numerous world-class strains such as Skunk #1, multiple Haze varieties and even the fabled Blueberry line (check out #11, #10 and #2). And, when grown right, Mexican sinsemilla (meaning “without seed”) can provide one of the best stand-alone sativa highs around.
 
24. Girl Scout Cookies
Highest lab-tested THC at a HT Cannabis Cup: 25.14 percent (Denver, 2013)
The GSC might be the youngest strain to earn a place on The List. She first appeared just a few years ago, circa 2011, and took the cannabis world by storm. Much controversy still surrounds this strain, however, and not just because of her name. A debate persists as to her lineage: The most commonly held belief is that she’s the product of OG Kush x Cherry Pie, while others contend that it was something called “F1” (not in reference to breeding) x Durban Poison, which was then crossed to Kush. Either way, the GSC has edged out some tough competition to make her appearance here.
 
23. Amnesia Haze
A classic strain from the Netherlands, the Amnesia Haze was winning Cups more than a decade ago and might be considered a fixture of the Amsterdam pot scene. A sativa-dominant hybrid, her ancestry looks something like this: (Afghani x Hawaiian) x Laos x Jamaican. This combination gives the Amnesia Haze a sweet and spicy flavor with a very cerebral high.
 
22. Critical Mass, a.k.a. Critical+
This one sparked a bit of internal debate here at High Times as to whether she merited inclusion on The List. However, in the end she won out over some of our honorable mentions (appearing at the end of this article) -- mostly due to her overwhelming popularity in Spain, which is fast becoming the new Amsterdam of Europe. Furthering her cause is her strong and flavorful high, for which a special nod to her folks, who rank at #11 and #6, is due.
 
21. Hindu Kush
This landrace strain is the primary reason the words “Kush” and “indica” have become synonymous. Originating in the Hindu Kush mountains of Afghanistan, this pure indica is responsible for such offspring as the Master Kush ... and she also played a role in the creation of our beloved OG Kush. Originally released by the stalwart Sensi Seeds, it’s rare to see these flowers around much these days, although her family still ranks among cannabis royalty.
 
20. Durban Poison
Highest lab-tested THC at a HT Cannabis Cup: 22.43 percent (Denver, 2013)
Another true landrace, the Durban is the only strain on The List that hails from Africa. A pure sativa, this variety has been used in a wide range of breeding projects, as she was one of the first strains out of South Africa that exhibited none of the auto-flowering traits of ruderalis, which are sometimes found in wild landrace lines. Lately, pure forms of Durban have been turning up at Cup competitions, and she has largely impressed with her licorice flavor and very potent “up” high.
 
19. White Widow
The White Widow was winning Cannabis Cups in Amsterdam as far back as 1995, and her actual birth date extends to nearly a decade before that. A well-balanced hybrid reportedly made by crossing a Brazilian sativa with an unknown indica from South India, she has both an indica-dominant and a sativa-dominant phenotype. Both phenos are usually thickly coated with trichomes, giving her a very white appearance (and, her name).
 
18. Thai Stick
Pure Thai, a landrace sativa, is still a favorite among cannabis connoisseurs. However, Thai Stick is a legendary strain with a twist -- and we mean that quite literally. It’s rumored that back in the 1960s, Thai Stick was pure Thai bud twisted around a stick -- but reports vary as to how the buds were attached. Some say it was with hemp rope; others say with pot leaves and stems; while still others say it was stuck on with opium! The latter would certainly explain why so many old heads have long craved the Thai Stick since her disappearance in the 1980s.
 
17. Chem ’91
Obviously, we couldn’t fit all of our favorite Chem Dog phenos here, since there are more than a few. But the ’91 is the first of the family to appear on The List, because she just might be the most flavorful of them all and has been widely used in crossbreeding projects (like the Deadhead OG) to get that sweet, Diesel-y taste that makes the mouth water and the lips pucker up. More on the Chem family when the 91’s big sis makes her appearance at #5.
 
16. Strawberry Cough
Highest lab-tested THC at a HT Cannabis Cup: 25.28 percent (Seattle, 2013)
This sativa-dominant hybrid produces a well-balanced but very uplifting high. The progeny of the Vermont-based indica Strawberry Fields and a mixed-breed Haze, the Strawberry Cough is revered among connoisseurs of fine cannabis for both her exquisite flavor (think berry) and high THC. When she’s grown organically -- or veganically, as some would have it -- she tops the THC charts and claims Cups as she should.
 
15. Grand Daddy Purple
Highest lab-tested THC at a HT Cannabis Cup: 18.60 percent (San Francisco, 2012)
This NorCal original started the purple- bud craze that helped push several very similar (if not identical) varieties out into a marketplace saturated with Kush and Diesel flavors. Offering a sweet and fruity taste of grape, the GDP stands out in a crowd and spurred the likes of Purple Urkel, the Purps and Grape Ape. Begat from an old Mendocino purple strain, this indica-dominant plant was used early and widely by California patients’ groups and has gone into the creation of several successful hybrid strains known for both flavor and heavy medicinal effects.
 
14. Cheese or Sensi Star? You decide ...
We need your help on this one! Should it be Cheese or Sensi Star that gets a spot on The List? Email hteditor@hightimes.com with your vote and put “Top 25” in the subject line. The winner will be named in an upcoming Cultivation Clinic column as the Featured Strain of the Month!
 
13. Super Lemon Haze
Highest lab-tested THC at a HT Cannabis Cup: 22.64 percent (Los Angeles Cup, 2012)
One of only two back-to-back Cannabis Cup champions, the Super Lemon Haze scored her wins in Amsterdam in 2008 and 2009. One of her parents, Super Silver Haze, was the only other strain to achieve this feat, back in 1998 and 1999 (more about her at #4). The Super Lemon Haze is a true Amsterdam original, created by the breeding giant Green House Seed Company as a cross of Lemon Skunk and Super Silver Haze. The Lemon Skunk half, which is native to the US, brings an overwhelming citrus flavor to the palate. Lab testing has shown extremely high profiles of limonene and terpinolene, making this super-sativa both tasty and potent.
 
12. G-13
The first (and, so far, only) known strain to be bred by the US government at this country’s sole legal cannabis-research facility at the University of Mississippi, the G-13 was secretly procured and brought to Holland circa 1986, where she fast became the mother to a host of epic strains. Because of her notoriety, most G-13 hybrids clearly state the parents in their name, like G-13 Haze (Cannabis Cup winner, 2007), G-13 Hashplant or Lemon G-13. Most recently, the G-13 was crossed with a Jack Herer male to produce the newly popular XJ-13.
 
11. Skunk #1
One of the first and best real hybrids of the modern cannabis-breeding era, Skunk #1 is a mix of three true-breeding landrace strains: Afghani (#6), Mexican (#25) and Colombian. This well-balanced beauty is a heavy yielder, doing well both indoors and out, filling gardens with that pungent, skunky aroma. She went on to play a role in the creation of such strains as Skunk- berry, Cheese, the Church, Island Sweet Skunk and Lemon Skunk, plus a couple
of other choice smokes you’ll see further down The List at #8 and #4.
 
10. Blueberry
Highest lab-tested THC at a HT Cannabis Cup: 17.45 percent (Seattle, 2013)
A perennial favorite with pot aficionados across the globe, the Blueberry could not be omitted from The List—and especially the top 10. Bred by DJ Short of Legends Seeds out of western Canada decades ago, the Blueberry is a powerful indica-dominant hybrid that has no less than eight distinct strains contributing to her lineage (yes, even some Mexican, for those of you reading the whole article)—a true benchmark of planned breeding.
 
9. Bruce Banner #3
Highest lab-tested THC at a HT Cannabis Cup: 28.35 percent (Denver, 2013)
The most potent strain ever tested in the history of the HIGH TIMES Cannabis Cup, the Bruce Banner was born and bred in Colorado and hit the 28 percent mark for THC, putting her squarely in The List’s Top 10.
 
The OG-dominant #3 phenotype was created in a hybridization project that crossed an OG Kush mother crossed with a Strawberry Diesel male. The #3 exhibits a nose-crackling, rocket-fuel aroma that scores high in flavor profiles -- including a tall order of the much-favored terpenoid limonene. If you haven’t tried out the Bruce Banner #3 yet, put her high on your list.
 
8. Cannatonic
Highest lab-tested CBD at a HT Cannabis Cup: 19.1 percent (Michigan, 2011)
Yes, that’s right, Cannatonic: This lovely lady earns a spot on The List for her contributions to the world of medical cannabis. While there are many CBD-rich strains out there, the Cannatonic has exhibited some of the highest CBD values ever recorded. In fact, one of her phenotypes, the Cannatonic X, which we came across in Michigan in 2011, went to 19 percent -- a true accomplishment for her breeders, and a real boon to patients and the medical community.
 
7. Northern Lights #5
Highest lab-tested THC at a HT Cannabis Cup: 18.71 percent (Denver, 2013)
One of the true all-time greats, the NL #5 was winning Cannabis Cups in Amster- dam way back in 1990. Grown and entered by the Seed Bank (one of the first such enterprises in the world for cannabis seeds), she was later released through the iconic Sensi Seeds and went on to play a role in producing generations of award-winning strains, including Super Silver Haze and Romulan. Another NorCal native, her lineage is unknown, but her taste and influence are not.
 
6. Afghani #1
So why we do call this keystone strain “Afghani,” as opposed to just “Afghan”? The answer reaches back into the history of this powerful indica, to a time when she was commonly called “Afghanica,” a reference to both her nation of origin and her classification as a truly pure indica variety. Today, the name has been shortened to the familiar “Afghani.” That being said, the Afghani #1 is one of only a handful of cornerstone genotypes that can be credited with aiding in the creation of nearly every major breeding achievement of the past 30 years. The Afghani is a major contributor to strains such as Skunk #1, the original Northern Lights, Sour Diesel, Cheese, Blueberry and Mazar, just to name a few.
 
5. Chem Dog
This slot isn’t just about the indica-heavy cannabis supermodel known as Chem Dog; it’s also a shout-out to all her sexy sister phenos (Chem ’04, Chem’s Sister and so on) that were spawned from the legendary 13 seeds found in a pound of Colorado kind bud purchased on a Grateful Dead tour back in the early ’90s. Out of those beans came a line that launched a whole new generation -- and genetics revolution, of sorts -- of the world’s newest and best marijuana. For her part, the Chem D has mothered more Cup-winning strains than any other in the current cen- tury, including the original OG Kush (and thus all other OG phenos), Sour Diesel, Stardawg and a whole host of Chem D crosses. Enough said.
 
4. Super Silver Haze
Highest lab-tested THC at a HT Cannabis Cup: 17.87 percent (Los Angeles, 2014) 
It’s no coincidence that the Super Silver Haze is the only other back-to-back champion in Cannabis Cup history. Both she and her daughter (Super Lemon Haze, at #18) are nearly one and the same when it comes to killer Haze strains, with the only real difference being the infusion of Lemon Skunk. Bred from superb Haze 
backcrosses, the SSH has all the true- breeding landrace sativas in her DNA, as well as a quarter NL #5 and a quarter Skunk #1. Make no mistake about it: The SSH was up for the #1 slot and might have gotten there if it wasn’t for the fact that the next three entries to come are...
 
3. Sour Diesel
Highest lab-tested THC at a HT Cannabis Cup: 19.50 percent (San Francisco, 2012) 
I won’t lie: If we were selfish people here at HIGH TIMES, the Sour Diesel would -- for sure -- be 
numero uno on The List. How- ever, as we explained in the opening to this article, there was more to the process of compiling these rankings than just personal (or personnel) preference. That being said, if there’s a tastier bud on the planet, we haven’t smoked it. When grown right, from the true East Coast cut (think AJ -- and true connoisseurs know what we mean here), there is simply no better flavor in cannabis. Period. The Sour Diesel reigns supreme on the east side of the United States and will be on The List for eternity.
 
2. Original Haze, a.k.a. Nevil’s Haze
Known to most simply as Haze, this lady also goes by the name Nevil’s Haze or A5 and was created by the Haze Brothers of Northern California. In the early ’80s, she was brought to Amsterdam by Dave Watson, a.k.a. Sam the Skunkman, where she was backcrossed and stabilized by Nevil, another of the legendary godfathers of breeding. A crossbreeding project of Mexican x Colombian x Thai x Indian (all landrace sativas), the Haze was a seminal import at the onset of the genetics trade that formed in Amsterdam during that time.
 
1. OG Kush
Highest lab-tested THC at a HT Cannabis Cup: 24.04 percent (Denver, 2013)
So here we are at #1... and there is no denying the OG Kush her rightful throne. The Queen of Cali is one of the most popular strains ever to grace the pages of High Times and is hands down the flower of choice on the West Coast of the United States. Not only is she one of the strongest strains on Earth, but she is also among the most varied, exhibiting more phenotypes than almost any other strain we’ve seen and demonstrating that she’s a true product of her environment.
 
When grown well, the OG Kush can take home a Cup in any competition, at any given time anywhere in the world, already claiming dozens of Cups via various OG phenos and crossbreeds. Nearly one out of every three new hybrids that come to market has the OG stamp in their genetic code, almost making the OG its own subspecies within the Cannabis genus. We all owe a debt of gratitude to the OG Kush for helping to usher in the next generation of excellent cannabis lines. Without a doubt, the OG is another strain that will forever be on The List.
 

After Marijuana Flops in Cancer Pain, Investors Look to the Future


After Marijuana Flops in Cancer Pain, Investors Look to the Future

Source: Flickr user Matthew Kenwrick.
For more than 15 years, GW Pharmaceuticals (NASDAQ: GWPH  ) has been researching marijuana cannabinoids (e.g. THC and CBD) in a bid to profit from pot. The company already has the THC-derived Sativex on the market in Europe as a treatment for multiple sclerosis spasticity, and it has a slate of clinical trials under way that are investigating THC and CBD's use across other indications. For now, however, medical marijuana's promise of profit has fallen short for the company.
Lacking demand
Despite being approved back in 2010 and being available in 27 countries, sales of Sativex remain a trickle. In fact, sales were so small for the drug that the company didn't even bother breaking them out for investors in its just-released fiscal-first-quarter earnings release.
Since the company didn't update Sativex's sales numbers, investors are probably correct to assume that they haven't budged much from fiscal 2014's $1.5 million to $2 million quarterly pace. If that's true, then it's unlikely that Sativex will ever become a top seller -- at least not as a European MS spasticity drug.
Source: GW Pharmaceuticals.
Overcoming disappointment
In January, Sativex's future as a cancer-pain treatment was somewhat dashed when GW Pharmaceuticals reported that data from the first of three phase 3 studies failed to outperform placebo. Although the company still has two additional Sativex cancer-pain trials ongoing, the failure of the first trial casts doubt on GW Pharmaceuticals' cannabinoid program and the company's ability to generate a significant revenue stream from it.
Investors will get more insight into GW Pharmaceuticals' opportunity in the cancer-pain indication when the second trial results become available in the second quarter; however, investors might be right to temper their expectations given that the second trial is identical in design to the failed first trial.
Instead, the company's best chance for success in the indication could prove to be the third trial, which was designed differently. Data from this third trial isn't expected until much later this year.
Targeting an unmet need
The company's cancer-pain stumble puts even more pressure on GW Pharmaceuticals' epilepsy-research program. In that program, the company is studying whether or not CBD, the non-psychotic chemical component of marijuana, can improve outcomes for patients suffering from both Dravet Syndrome and Lennox-Gastaut syndrome -- two rare forms of epilepsy that currently have few treatment options.
GW Pharmaceuticals reports that it has completed enrollment in part A of its phase 2/3 Dravet syndrome trial, and that it will commence the part B phase of that trial this quarter. A second phase 3 trial for Dravet is expected to complete enrollment by the end of the year, too. Two phase 3 trials in Lennox-Gastaut will also get under way this quarter, and enrollment in those trials should also be complete by year's end.
There's little doubt that a new treatment option for these two conditions would be very welcome by patients and prescribers. Currently, there is no standard of care in treating these patients beyond daily anticonvulsants. However, investors should recognize that these are small patient populations. There are only about 5,000 to 6,000 cases of Dravet in the United States, and half that number of cases of Lennox-Gastaut. Regardless, the company expects that investors will be able to digest data results from at least one of these epilepsy trials by the end of 2015.
Advancing other programs
Although the cancer-trial failure shifts a lot of investor focus to GW Pharmaceuticals' epilepsy trials, the company is also researching whether or not marijuana cannabinoids could help patients with other conditions, too. The company hopes to report results from a phase 2a trial of GWP42003 in schizophrenia patients in the second half of this year, and GW Pharmaceuticals' phase 2b study of GWP42004 as a type-2 diabetes therapy is expected to have data available in 2016. Beyond those programs, GW Pharmaceuticals is also conducting studies of marijuana cannabinoids as a brain-cancer treatment.
Looking forward
Although the company's medical-marijuana programs were dealt a blow when the first cancer-pain trial results were announced, investors appear content to wait and see the additional cancer-pain trial results and the results from the epilepsy trials before selling shares.
That approach could prove to be risky. Shares of GW Pharmaceuticals have climbed 80% since the end of 2013, and with little revenue from Sativex, a stumble in the remaining two cancer-pain trials could significantly dent the company's peak sales potential.
Regardless, investors can take some solace in knowing that GW Pharmaceuticals has plenty of cash on hand to continue funding its research. Exiting the fiscal first quarter, cash and equivalents totaled $243.9 million. That should be plenty to keep the lights on.
This coming blockbuster will make every biotech jealousThe best biotech investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that could revolutionize not just how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. If you hope to outsmart Wall Street and realize multi-bagger returns you will need to get in early -- check out The Motley Fool’s new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.

Toronto companies looking for global profits with marijuana software


Toronto companies looking for global profits with marijuana software





Amid the buzz of a burgeoning medical marijuana industry, Toronto tech companies are passing over pot for the potential windfall of marijuana software.
While medical marijuana growers are looking to cash in on an industry expected to reach $1.4 billion in Canada by 2024, these software companies have their eyes set on a U.S. market already worth $2.3 billion and global markets beyond that.
Ample Organics only launched its seed-to-sale software in January and already the company has doubled in size and landed Aphria Inc., one of only three publicly-traded licensed marijuana producers in Canada, as its newest client.

“That’s a huge one for us,” said president John Prentice, 30.
Even so, the Canadian market is “tiny” compared to the U.S., he said, and Ample Organics is pitching Oregon State to provide their entire state tracking system, with plans to officially launch in U.S. in May. The company also has “feet on the ground” in the Bahamas.
Grow One, another Toronto-based company promising to “manage virtually every aspect of your production,” also has its sights set south of the border.
The company raised $1 million to work with five licensed producers, six applicants, a lab company and consultants to perfect its system before launching, said Peter Barbosa, 26, Grow One founder and CEO.
“This is just the start of something big,” Barbosa said.
“Canada is a small market,” he said, and the company is “excited” to jump in the U.S., where 23 states allow medical marijuana.
Prentice and Barbosa both founded their companies after realizing that existing software wasn’t set up to handle the complex regulatory world within which growers will have to operate.
Entrepreneurs face numerous hurdles beyond growing good pot. Health Canada’s stringent regulations include careful monitoring and quality controls on the products. Companies also have to manage the sales, shipping and customer relations and must also comply with Health Canada audits.
“We have the strictest regulations on medical marijuana anywhere in the world,” Prentice said. “The reporting capabilities and record keeping requirements are extensive.”
Barbosa warned the industry is still in its infancy. He said Grow One wants to be the best software on the market — not the first.
But Prentice thinks 2015 will be a crucial year for the medical marijuana industry.
“This is going to be the year the doors close on companies that want to work with licensed producers,” he said.

Early death more likely in areas with lots of alcohol outlets


Early death more likely in areas with lots of alcohol outlets

Toronto: Scientists have found a link between the density of both cheque-cashing places and alcohol outlets in a given neighbourhood and the risk of premature death.
Early death more likely in areas with lots of alcohol outlets
The relation was stronger in men than in women, according to Dr Flora Matheson and Dr Joel Ray from St Michael's Hospital, Canada.
The findings suggest that the strategic placement of cheque-cashing places and alcohol outlets in certain areas may provide local residents with ready access to quick cash and the purchase of alcohol.
Matheson, a medical sociologist and research scientist, said this is particularly true in the holiday season, when banks may be closed, people need money quickly and alcohol sales go up dramatically.
However, the authors do not say that cheque-cashing or alcohol outlets directly play a role in premature deaths.
Their survey of Toronto's 140 neighbourhoods found that men had a 1.25 times greater risk of premature death in areas with high densities of cheque cashing places.
They had a 1.36 times greater risk of premature death in areas with high densities of alcohol outlets - alcohol and beer stores and on-premise licensed facilities such as bars.
The premature mortality rate was 96.3 for every 10,000 males and 55.9 for every 10,000 females ages 20-59 years.
The researchers looked at people ages 20-59 only, so as to eliminate causes of premature death traditionally related to newborns, children and seniors.
Intentional self-harm, accidental poisoning and liver disease are among the top five causes of premature death among men ages 20-59, and many of these deaths are highly preventable, they said.
A substantial amount of research has been conducted on the relation between neighbourhoods and residents' health.
Neighbourhood disadvantage is associated with poor psychological and physical health. However, the current study already factors in neighbourhood income and crime rates.
While there is some compelling evidence around limiting the number of alcohol outlets and hours of operation, less is known about cheque-cashing places.
Researchers said this is the first study to examine the relation between cheque-cashing places and premature death.
The study was published in the journal BMJ Open.

Cannabis is the single most versatile herbal remedy


Study: Medical Marijuana Works for 92 Percent of Patients

Study: Medical Marijuana Works for 92 Percent of Patients




There are naysayers who believe the concept of medical marijuana is really just an elaborate scheme intended to move cannabis into the American mainstream, with people like former New York mayor Michael Bloomberg calling it “one of the greatest hoaxes of all time.” However, a new survey released this week by the Public Health Institute finds the majority of medical marijuana patients in California -- 92 percent -- agree that the herb has been beneficial in calming the symptoms of their suffering from conditions like cancer, chronic pain and migraine headaches.
The latest statistics, which were produced under the thumb of the Centers for Disease Control and Prevention using data from the California Behavioral Risk Surveillance System, were determined by polling 7,525 legal adults who reside in the state of California. What they found was that five percent of the respondents, from every age range, claimed to have used medical marijuana to combat a “serious medical condition.”
"Our study’s results lend support to the idea that medical marijuana is used equally by many groups of people and is not exclusively used by any one specific group," wrote the study authors. In fact, both men and women reported similar usage rates, but the younger end of the spectrum conveyed the bulk of its use.
Although the survey did uncover a certain level of racial disparity in medical marijuana users, researchers insisted "the absolute difference in prevalence between the racial/ethnic groups is less than three percentage points, which may not have much importance in practical terms."
Interestingly, even though medical marijuana has been legalized in 23 states, opposing forces continue to suggest it is a scam. Yet, the latest study results strongly disagree with this sentiment. "Our study contradicts commonly held beliefs that medical marijuana is being overused by healthy individuals," wrote the study authors. "The most common reasons for use include medical conditions for which mainstream treatments may not exist, such as for migraines, or may not be effective, including for chronic pain and cancer."
Perhaps it is time for lawmakers to start listening to the patients when it comes to medical marijuana legislation. This study makes it perfectly clear that if there is a “con” in the realm of the medicinal cannabis industry, it lies in the politics of the argument, not in the medicine.
(Photo c/o gazzettenet.com)


There are naysayers who believe the concept of medical marijuana is really just an elaborate scheme intended to move cannabis into the American mainstream, with people like former New York mayor Michael Bloomberg calling it “one of the greatest hoaxes of all time.” However, a new survey released this week by the Public Health Institute finds the majority of medical marijuana patients in California -- 92 percent -- agree that the herb has been beneficial in calming the symptoms of their suffering from conditions like cancer, chronic pain and migraine headaches.
The latest statistics, which were produced under the thumb of the Centers for Disease Control and Prevention using data from the California Behavioral Risk Surveillance System, were determined by polling 7,525 legal adults who reside in the state of California. What they found was that five percent of the respondents, from every age range, claimed to have used medical marijuana to combat a “serious medical condition.”
"Our study’s results lend support to the idea that medical marijuana is used equally by many groups of people and is not exclusively used by any one specific group," wrote the study authors. In fact, both men and women reported similar usage rates, but the younger end of the spectrum conveyed the bulk of its use.
Although the survey did uncover a certain level of racial disparity in medical marijuana users, researchers insisted "the absolute difference in prevalence between the racial/ethnic groups is less than three percentage points, which may not have much importance in practical terms."
Interestingly, even though medical marijuana has been legalized in 23 states, opposing forces continue to suggest it is a scam. Yet, the latest study results strongly disagree with this sentiment. "Our study contradicts commonly held beliefs that medical marijuana is being overused by healthy individuals," wrote the study authors. "The most common reasons for use include medical conditions for which mainstream treatments may not exist, such as for migraines, or may not be effective, including for chronic pain and cancer."
Perhaps it is time for lawmakers to start listening to the patients when it comes to medical marijuana legislation. This study makes it perfectly clear that if there is a “con” in the realm of the medicinal cannabis industry, it lies in the politics of the argument, not in the medicine.
(Photo c/o gazzettenet.com)

Why You Think Cannabis is Illegal - Why Cannabis is really Illegal?




THIS IS OFFICIALLY COPYRIGHTED BY BRADLEY WALKER:... See More
 — with Bradley WalkerFrank KnightJeff D NevesSergio De La OJulie RoseGo GreenJacky OldhamDan EyreFay McKinneyStephanie Lynn MathisBrandon WeldonDavid Nucleo AlexanderRickshaw DaveAnthony Cicalla JuniorMike Boutinhttp://www.jackherer.com/thebook/ in your photoThomas JamesConstance FinleyClaude Morton and Brian K. Weikel.
I ENCOURAGE PEOPLE TO SHARE THIS, I SIMPLY ASK THAT TRUTHJUSTICEWISDOM IS GIVEN CREDIT AND A LINK IS PROVIDED TO THIS PIC AND/OR THE GROUP.
https://www.facebook.com/photo.php?fbid=542905385741211
https://www.facebook.com/photo.php?fbid=542901495741600

My goal with this project was to undo 80 years of lies and propaganda with a single powerful image. I spent over a hundred hours researching these corporations and designing the image. I actually looked up the specific products and policies of each company, to make sure that they would truly benefit from the continued criminalization of a natural plant. For example, if a pharmaceutical company only produced cholesterol medication, I didn't include them, since cannabis isn't known to help with that. And if a company is in the process of promoting clean energy and renewable resources, I didn't include them either. So I feel pretty confident in saying this graphic accurately represents the 'bad guys' who most likely secretly spend $ on anti-legalization advertising and political campaign donations to ensure cannabis' continued illegality.

The yellow text found on the bottom of the green mini-charts says:
"Modern Uses" chart made by Dominic Cramer of Toronto Hemp Company www.torontohemp.com (used with his permission, and he is partially credited in Copyright)
Inspired by Jack Herer's "The Emperor Wears No Clothes" www.jackherer.com
Corporate logos, propaganda posters, and boxes/arrows/text added by Bradley Walker


This went viral back in March 2012. The original picture quickly got up to 5,000+ Shares before Facebook deleted it for "copyright infringement", supposedly for using the corporate logos which should be considered public domain usage since I'm not trying to make $ with this. Luckily it spread fast enough that deleting my original didn't make a difference - the information was already out there. I have since added the Fair Use Disclaimer and gotten this approved and copyrighted by the US Copyright Office.

Please share, let's get the truth out there! (But please give credit and provide this link, as stated at the beginning.) And to see the large legible high-res version of the image, just click the "Download" link on the side. I also suggest downloading this and printing out fliers, making signs, putting it on city billboards, etc.

"3 things will not long be hidden - the Sun, the Moon, and the Truth."
-Prince Gautama Siddharta, the original "Buddha" or "enlightened one", the founder of Buddhism, 563-483 B.C.

HELPFUL RESOURCES BELOW:

----------------------

Regulations and restrictions on the sale of cannabis sativa as a drug began as early as 1860. The head of the Federal Bureau of Narcotics (FBN), Harry J. Anslinger, argued that, in the 1930s, the FBN had noticed an increase of reports of people smoking marijuana. He had also, in 1935, received support from president Franklin D. Roosevelt for adoption of the Uniform State Narcotic Act, state laws that included regulations of cannabis.

Some parties have argued that the aim of the Act was to reduce the size of the hemp industry largely as an effort of businessmen Andrew Mellon, Randolph Hearst, and the Du Pont family. The same parties have argued that with the invention of the decorticator, hemp had became a very cheap substitute for the paper pulp that was used in the newspaper industry. These parties argue that Hearst felt that this was a threat to his extensive timber holdings. Mellon, Secretary of the Treasury and the wealthiest man in America, had invested heavily in the Du Pont family's new synthetic fiber, nylon, a fiber that was competing with hemp. In 1916, United States Department of Agriculture (USDA) chief scientists Jason L. Merrill and Lyster H. Dewey created a paper, USDA Bulletin No. 404 "Hemp Hurds as Paper-Making Material", in which they concluded that paper from the woody inner portion of the hemp stem broken into pieces, so called hemp hurds, was "favorable in comparison with those used with pulp wood". Dewey and Merrill believed that hemp hurds were a suitable source for paper production.

http://www.erowid.org/plants/cannabis/cannabis_culture11.shtml

----------------------

http://mendonews.wordpress.com/2010/08/30/henry-ford-and-rudolf-diesels-vision-of-a-hemp-diesel-revolution/

http://en.wikipedia.org/wiki/Hemp

FAIR USE NOTICE: This infographic may contain copyrighted material the use of which has not been specifically authorized by the copyright owner. We are making such material available in an effort to advance understanding of environmental, political, economic, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this infographic is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. All trademarks belong to their respective owners.
 — with Bradley WalkerFrank KnightJeff D Neves